← Back to Search

Apple Watch for Pediatric Arrhythmia (PAWS Trial)

N/A

Waitlist Available

Led By Scott Ceresnak, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

PAWS Trial Summary

This trial tests if the Apple Watch ECG is accurate in measuring heart rate in kids, and if it can detect undiagnosed heart conditions.

Who is the study for?

This trial is for children and young adults aged 6 to 21 who are undergoing monitoring for heart rhythm problems. Participants must be able to wear an Apple Watch safely and use its features, including the trigger buttons.Check my eligibility

What is being tested?

The study aims to test how accurately the Apple Watch can record ECG tracings and heart rate in kids. It also looks at whether using the watch longer term catches any arrhythmias that shorter clinical tests might miss.See study design

What are the potential side effects?

Wearing an Apple Watch is generally safe but may include discomfort from wearing the device continuously or skin irritation. The study does not involve medication, so drug-related side effects are not expected.

PAWS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 6 and 21 years old and need heart rhythm monitoring.

PAWS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Arrhythmia correlation

Heart rate correlation

PAWS Trial Design

1Treatment groups

Experimental Treatment

Group I: Apple WatchExperimental Treatment1 Intervention

Participants will wear an Apple Watch for 6 months

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Apple Watch

2015

N/A

~440

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,250 Total Patients Enrolled

Scott Ceresnak, MDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment admit participants who are over the age of 20?

"To be considered for this medical experiment, prospective participants must between 6 and 21 years old."

Answered by AI

Is my eligibility sufficient to parttake in this trial?

"In order to be qualified for this trial, candidates must have pediatric arrhythmia and be between 6-21 years of age. The research team is aiming to recruit a total of 100 participants."

Answered by AI

Are any new participants being admitted to this trial at present?

"After consulting clinicaltrials.gov, it appears that this medical trial is no longer enrolling patients; the first posting was on November 1st 2023 and the last update occurred on September 22nd 2023. However, there are 67 other trials actively recruiting participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pediatric Apple Watch Study

Scott Ceresnak 2024. "Pediatric Apple Watch Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06053372.